The UK government has issued an update regarding suspected adverse events associated with the use of Arthramid Vet in horses. This notification follows increased discussions on social media about potential issues with the treatment.
What is Arthramid Vet?
Arthramid Vet, a 2.5% polyacrylamide hydrogel (PAAG), is used by veterinarians worldwide to treat joint lameness and osteoarthritis in horses. It works by enhancing the viscoelasticity of the synovial fluid and integrating into the synovial lining.
Reporting Adverse Events
The UK government emphasizes the importance of reporting any adverse events related to veterinary medicines. An adverse event is defined as any unfavourable and unintended observation in animals after the use of a veterinary medicine, whether or not it is considered product-related.
Points to Consider:
- Definition of Adverse Events: Any observation in animals that is unfavourable and unintended after using a veterinary medicine.
- Reporting Mechanism: Adverse events can be reported to the company, the Marketing Authorisation Holder (MAH), or directly to the Veterinary Medicines Directorate (VMD).
- Importance of Reporting: Continuous monitoring by the VMD’s pharmacovigilance team helps in assessing the safety of veterinary medicines.
Safety and Efficacy of Arthramid Vet
Despite the recent discussions, multiple studies have shown that Arthramid Vet is generally safe and effective.
Numerous studies have consistently found that Arthramid Vet significantly reduces lameness compared to other treatments, such as triamcinolone acetonide (TA) and hyaluronic acid (HA).
Moreover, in these studies, researchers have reported no adverse reactions, further underscoring Arthramid Vet’s efficacy and safety.
How to Report Adverse Events
If you suspect an adverse event related to Arthramid Vet or any other veterinary medicine, you can report it using the following steps:
- Company or MAH: Report to the company or the Marketing Authorisation Holder listed on the product leaflet.
- VMD: Use the online reporting form available on the VMD website.
In Conclusion
The UK government’s update on Arthramid Vet adverse events underscores the need for vigilant monitoring and reporting of any suspected issues.
Numerous studies have shown Arthramid Vet to be effective and safe; however, veterinarians and horse owners must be aware of reporting mechanisms and promptly report any adverse events.
Sources: THX News & Veterinary Medicines Directorate.
